NXTMH Stock Overview
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Nexstim Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.30 |
| 52 Week High | €3.95 |
| 52 Week Low | €2.03 |
| Beta | 1.35 |
| 1 Month Change | 4.55% |
| 3 Month Change | -4.56% |
| 1 Year Change | -36.11% |
| 3 Year Change | -61.21% |
| 5 Year Change | -87.15% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Is Now The Time To Look At Buying Nexstim Plc (HEL:NXTMH)?
Nov 17
Nexstim's (HEL:NXTMH) Promising Earnings May Rest On Soft Foundations
Aug 20At €4.73, Is Nexstim Plc (HEL:NXTMH) Worth Looking At Closely?
Aug 15Is Nexstim (HEL:NXTMH) A Risky Investment?
Jun 14Nexstim (HEL:NXTMH) Has Debt But No Earnings; Should You Worry?
Dec 02Is Nexstim (HEL:NXTMH) Using Debt In A Risky Way?
Aug 18Shareholder Returns
| NXTMH | FI Medical Equipment | FI Market | |
|---|---|---|---|
| 7D | 3.1% | -1.4% | 1.6% |
| 1Y | -36.1% | -35.3% | -13.6% |
Return vs Industry: NXTMH underperformed the Finnish Medical Equipment industry which returned -34.1% over the past year.
Return vs Market: NXTMH underperformed the Finnish Market which returned -12.9% over the past year.
Price Volatility
| NXTMH volatility | |
|---|---|
| NXTMH Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FI Market | 7.6% |
| 10% least volatile stocks in FI Market | 3.1% |
Stable Share Price: NXTMH has not had significant price volatility in the past 3 months.
Volatility Over Time: NXTMH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 37 | Mikko Karvinen | www.nexstim.com |
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company’s navigated transcranial magnetic stimulation (nTMS) technology utilizes 3D navigation for providing accurate and personalized targeting of the TMS to the specific areas of the brain. It also offers Navigated Brain Therapy system, a navigated brain therapy system for the treatment of major depressive disorder (MDD) and chronic neuropathic pain; and Navigated Brain Stimulation (NBS) system, a navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.
Nexstim Plc Fundamentals Summary
| NXTMH fundamental statistics | |
|---|---|
| Market cap | €15.56m |
| Earnings (TTM) | -€1.33m |
| Revenue (TTM) | €8.58m |
1.8x
P/S Ratio-11.7x
P/E RatioIs NXTMH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXTMH income statement (TTM) | |
|---|---|
| Revenue | €8.58m |
| Cost of Revenue | €1.60m |
| Gross Profit | €6.98m |
| Other Expenses | €8.31m |
| Earnings | -€1.33m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 16, 2024
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 81.35% |
| Net Profit Margin | -15.46% |
| Debt/Equity Ratio | 156.4% |
How did NXTMH perform over the long term?
See historical performance and comparison